NS

Nityananda Saha

Active Director Director DIN 10256539
DIN 10256539 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Nityananda Saha

Data last updated:

Nityananda Saha is a Director at Ntree Biotech Private Limited (since 2023). The company operates in Paper. Ntree Biotech Private Limited reported revenue of ₹10.8 Lakh (FY 2025).

DIN 10256539
Primary Designation Director
Industry Paper
First Appointment 27 Jul 2023
Oldest Company Age 3 yrs
Largest company Ntree Biotech Private Limited · ₹10.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ntree Biotech Private Limited U21002WB2023PTC263849
Director27 Jul 20232023₹10.8 Lakh (FY 2025)Active

Board colleagues of Nityananda Saha

NameDINCompanyDesignation
Sudeshna Saha10256538Ntree Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ntree Biotech Private Limited
Premium access

Shareholding and investment profile for Nityananda Saha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nityananda Saha

Nityananda Saha currently holds 1 directorship: Ntree Biotech Private Limited (Director, since 27 Jul 2023, revenue ₹10.8 Lakh (FY 2025)).

Nityananda Saha was first appointed on 27 Jul 2023 as Director at Ntree Biotech Private Limited.

The current boards of Nityananda Saha's companies include Sudeshna Saha (Ntree Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available